Here’s what Jim Cramer thinks about J&J stock after a pivotal talc case verdict

Health, Fitness & Food

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. 
Justin Sullivan | Getty Images

A closely watched talc trial in California goes against Johnson & Johnson (JNJ), adding uncertainty around whether tens of thousands of other plaintiffs suing the company will sign on to J&J’s proposed $8.9 billion settlement offer or seek to get their own days in court.

Products You May Like

Articles You May Like

Lemongrass Chicken Noodle Bowls
Spinach Feta Frittata
FDA cancels vaccine advisory meeting for choosing flu strains for next season’s shots
Why Do We Expect Celebrities to Look the Same Forever?
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

Leave a Reply

Your email address will not be published. Required fields are marked *